Peter Greven GmbH & Co. KG – Trademark Portfolio
Entity Type: 28
Peter Greven GmbH & Co. KG holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 9 filings in this category. The portfolio also extends into Class 4 (Lubricants & Fuels) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include LIGALUB and LIGAPHOB.
Peter-Greven-Str. 20-30
53902 Bad Münstereifel
Showing of trademarks Trademarks
Trademark Classifications
Peter Greven GmbH & Co. KG's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Industrial oils and greases; lubricants; dust absorbing, wetting and binding compositions
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does Peter Greven GmbH & Co. KG have?
Peter Greven GmbH & Co. KG has 9 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does Peter Greven GmbH & Co. KG file in?
Peter Greven GmbH & Co. KG files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 4 (Lubricants & Fuels), Class 3 (Cosmetics & Cleaning). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are Peter Greven GmbH & Co. KG's most well-known trademarks?
Peter Greven GmbH & Co. KG's registered trademark portfolio includes well-known marks such as LIGALUB and LIGAPHOB. These are among 2 currently registered trademarks in the portfolio.
What is Peter Greven GmbH & Co. KG's trademark registration success rate?
Peter Greven GmbH & Co. KG has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.